0
TECHNICAL BRIEFS

Biological Activity of rhBMP-2 Released From PLGA Microspheres

[+] Author and Article Information
J. B. Oldham, L. Lu, X. Zhu, B. D. Porter, B. L. Currier, M. J. Yaszemski

Departments of Orthopedic Surgery and Bioengineering, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

T. E. Hefferan

Department of Protein Chemistry and Molecular Biology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

D. R. Larson

Department of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

A. G. Mikos

Department of Bioengineering, Rice University, Houston, TX 77005

J Biomech Eng 122(3), 289-292 (Feb 06, 2000) (4 pages) doi:10.1115/1.429662 History: Received October 21, 1999; Revised February 06, 2000
Copyright © 2000 by ASME
Your Session has timed out. Please sign back in to continue.

References

LeGrand,  K. K., 1998, “Preclinical Promise of Becaplermin (rhPDGF-BB) in Wound Healing,” Am. J. Surg., 176, pp. 48S–54S.
Robson,  M. C., Mustoe,  T. A., and Hunt,  T. K., 1998, “The Future of Recombinant Growth Factors in Wound Healing,” Am. J. Surg., 176, pp. 80S–82S.
Wu,  D., and Zhao,  D., 1997, “Tissue Engineering Study on Repairment of Injured Nerve Gap in Rat,” J. Biomed. Eng., 14, pp. 108–110.
Reddi,  A. H., 1998, “Role of Morphogenetic Proteins in Skeletal Tissue Engineering and Regeneration,” Nat. Biotechnol., 16, pp. 247–252.
Wozney,  J. M., 1989, “Bone Morphogenetic Proteins,” Prog. Growth Factor Res., 1, pp. 267–280.
Wozney,  J. M., Rosen,  V., and Celeste,  A. J., 1988, “Novel Regulators of Bone Formation: Molecular Clones and Activities,” Science, 242, pp. 1528–1534.
Lee,  M. B., 1997, “Bone Morphogenetic Proteins: Background and Implications for Oral Reconstruction: A Review,” J. Clin. Periodontol., 24, pp. 355–365.
Mimatsu,  K., Kishi,  S., and Hashizume,  Y., 1997, “Experimental Chronic Compression on the Spinal Cord of the Rabbit by Ectopic Bone Formation in the Ligamentum Flavum With Bone Morphogenetic Protein,” Spinal Cord, 35, pp. 740–746.
Cole,  B. J., Bostrom,  M. P., Pritchard,  T. L., Sumner,  D. R., Tomin,  E., Lane,  J. M., and Weiland,  A. J., 1997, “Use of Bone Morphogenetic Protein 2 on Ectopic Porous Coated Implants in the Rat,” Clin. Orthop. Relat. Res., 345, pp. 219–228.
Wang,  E. A., Rose,  V., and D’Alessandro,  J. S., 1990, “Recombinant Human Bone Morphogenetic Protein Induces Bone Formation,” Proc. Natl. Acad. Sci. USA, 87, pp. 2220–2224.
Yasko,  A. W., Lane,  J. M., Fellinger,  E. J., Rosen,  V., Wozney,  J. M., and Wang,  E. A., 1992, “The Healing of Segmental Bone Defects, Induced by Recombinant Human Bone Morphogenetic Protein (rhBMP-2),” J. Bone Jt. Surg., 74-A, pp. 659–671.
Cleek,  R. L., Ting,  K. C., Eskin,  S. G., and Mikos,  A. G., 1997, “Microparticles of Poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) Blends for Controlled Drug Delivery,” J. Controlled Release, 48, pp. 259–268.
Peter, S. J., Lu, L., Kim, D. J., Stamatas, G. N., Miller, M. J., Yaszemski, M. J., and Mikos, A. G., 2000, “Effects of TGF-β1 Released from Biodegradable Polymer Microparticles on Marrow Stromal Osteoblasts Cultured on Poly(propylene fumarate) Substrates,” J. Biomed. Mater. Res., in press.
Thompson,  R. C., Mikos,  A. G., Beahm,  E., Lemon,  J. C., Satterfield,  W. C., Aufdemorte,  T. B., and Miller,  M. J., 1900, “Guided Tissue Fabrication From Periosteum Using Preformed Biodegradable Polymer Scaffolds,” Biomaterials, 20, pp. 2007–2018.
Harris,  S. A., Enger,  R. J., Riggs,  B. L., and Spelsberg,  T. C., 1995, “Development and Characterization of a Conditionally Immortalized Human Fetal Osteoblastic Cell Line,” J. Bone Miner. Res., 10, pp. 178–186.
Kawasaki,  K., Aihara,  M., Honmo,  J., Sakurai,  S., Fujimaki,  Y., Sakamoto,  K., Fujimaki,  E., Wozney,  J. M., and Yamaguchi,  A., 1998, “Effects of Recombinant Human Bone Morphogenetic Protein-2 on Differentiation of Cells Isolated From Human Bone, Muscle, and Skin,” Bone, 23, pp. 223–231.
Murata,  M., Inoue,  M., Arisue,  M., Kuboki,  Y., and Nagai,  N., 1998, “Carrier-Dependency of Cellular Differentiation Induced by Bone Morphogenetic Protein in Ectopic Sites,” Int. J. Oral Maxillofac Surg., 27, pp. 391–396.
Centrella,  M., McCarthy,  T. L., and Canalis,  E., 1987, “Transforming Growth Factor-β is a Bifunctional Regulator of Replication and Collagen Synthesis in Osteoblast-Enriched Cell Cultures From Fetal Rat Bone,” J. Biol. Chem., 262, pp. 2869–2874.
Rosen,  D. M., 1994, “Transforming Growth Factor-βs: Biological Activities Related to Bone Metabolism,” J. Bone Miner. Res., 8, pp. 143–166.
Theis,  R. S., Bauduy,  M., Ashton,  B. A., Kurtzberg,  L., Wozney,  J. M., and Rosen,  V., 1992, “Recombinant Human Bone Morphogenetic Protein-2 Induces Osteoblastic Differentiation in W-20-17 Stromal Cells,” Endocrinology, 130, pp. 1318–1324.
Puleo,  D. A., Huh,  W. W., Duggirala,  S. S., and Deluca,  P. P., 1998, “In Vitro Cellular Responses to Bioerodible Particles Loaded With Recombinant Human Bone Morphogenetic Protein-2,” J. Biomed. Mater. Res., 41, pp. 104–110.

Figures

Grahic Jump Location
Graphic representation of ALP/protein in cultured osteoblasts shown in Table 1

Tables

Errata

Discussions

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In